BR0206502A - Antagonistas do receptor de histamina - Google Patents

Antagonistas do receptor de histamina

Info

Publication number
BR0206502A
BR0206502A BR0206502-9A BR0206502A BR0206502A BR 0206502 A BR0206502 A BR 0206502A BR 0206502 A BR0206502 A BR 0206502A BR 0206502 A BR0206502 A BR 0206502A
Authority
BR
Brazil
Prior art keywords
histamine
receptor antagonists
receptor
histamine receptor
antagonist
Prior art date
Application number
BR0206502-9A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR0206502A publication Critical patent/BR0206502A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"ANTAGONISTAS DO RECEPTOR DE HISTAMINA". A presente invenção fornece uma combinação de (a) um antagonista do receptor de histamina H, e (b) um antagonista que é pelo menos dez vezes mais seletivo para o receptor de histamina H~ 4~ quando comparado com o receptor de histamina H~ 3~ e um antagonista que é pelo menos dez vezes mais seletivo para o receptor de histamina H~ 4~ quando comparado com o receptor de histamina H~ 3~, e suas composições.
BR0206502-9A 2001-01-17 2002-01-10 Antagonistas do receptor de histamina BR0206502A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists
PCT/IB2002/000042 WO2002056871A2 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
BR0206502A true BR0206502A (pt) 2003-10-21

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0206502-9A BR0206502A (pt) 2001-01-17 2002-01-10 Antagonistas do receptor de histamina

Country Status (32)

Country Link
EP (1) EP1353657A1 (pt)
JP (1) JP2004517883A (pt)
KR (1) KR20030069216A (pt)
CN (1) CN1486178A (pt)
AP (1) AP2002002401A0 (pt)
AR (1) AR032101A1 (pt)
BG (1) BG107834A (pt)
BR (1) BR0206502A (pt)
CA (1) CA2435121A1 (pt)
CR (1) CR6983A (pt)
CZ (1) CZ20031853A3 (pt)
DO (1) DOP2002000325A (pt)
EA (1) EA200300537A1 (pt)
EC (1) ECSP034692A (pt)
EE (1) EE200300335A (pt)
GB (1) GB0101223D0 (pt)
GT (1) GT200200003A (pt)
HU (1) HUP0302767A2 (pt)
IL (1) IL156087A0 (pt)
IS (1) IS6818A (pt)
MA (1) MA26980A1 (pt)
MX (1) MXPA03006408A (pt)
NO (1) NO20033223L (pt)
OA (1) OA12440A (pt)
PA (1) PA8537101A1 (pt)
PL (1) PL362793A1 (pt)
PY (1) PY0200477A (pt)
SK (1) SK8572003A3 (pt)
SV (1) SV2003000849A (pt)
TN (1) TNSN02003A1 (pt)
WO (1) WO2002056871A2 (pt)
ZA (1) ZA200304180B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
CA2497788A1 (en) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Use of histamine h4 receptor modulators for the treatment of allergy and asthma
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
PL2858647T3 (pl) 2012-06-08 2018-10-31 Sensorion Inhibitory receptora h4 do leczenia szumów usznych
CN119823227B (zh) * 2025-01-14 2025-07-04 广州迪卡德营养科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Also Published As

Publication number Publication date
HUP0302767A2 (hu) 2003-11-28
DOP2002000325A (es) 2003-01-31
IS6818A (is) 2003-05-15
EE200300335A (et) 2003-12-15
CA2435121A1 (en) 2002-07-25
PL362793A1 (pl) 2004-11-02
IL156087A0 (en) 2003-12-23
BG107834A (bg) 2004-01-30
TNSN02003A1 (fr) 2005-12-23
WO2002056871A2 (en) 2002-07-25
NO20033223D0 (no) 2003-07-16
JP2004517883A (ja) 2004-06-17
GB0101223D0 (en) 2001-02-28
PY0200477A (es) 2004-06-01
PA8537101A1 (es) 2002-08-29
SK8572003A3 (en) 2004-07-07
AP2002002401A0 (en) 2002-03-31
CN1486178A (zh) 2004-03-31
ECSP034692A (es) 2003-08-29
MXPA03006408A (es) 2003-10-15
EA200300537A1 (ru) 2004-02-26
OA12440A (en) 2006-05-22
NO20033223L (no) 2003-07-16
SV2003000849A (es) 2003-01-13
AR032101A1 (es) 2003-10-22
ZA200304180B (en) 2004-06-15
EP1353657A1 (en) 2003-10-22
KR20030069216A (ko) 2003-08-25
CZ20031853A3 (cs) 2004-07-14
CR6983A (es) 2003-11-25
GT200200003A (es) 2002-08-19
MA26980A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
AU2003246811A8 (en) Terphenyl derivatives, preparation thereof, compositions containing same
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
ATE297910T1 (de) Retinoid x rezeptormodulatoren
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
BR0308339A (pt) Indazóis substituìdos com uma atividade anticancerosa
MY117251A (en) Use of central cannabinoid receptor antagonists for the preparation of drugs
DE69732868D1 (de) Mittel gegen Juckreiz
BR0204001A (pt) Forma de dosagem oral sólida de simeticona
BRPI0409910A (pt) métodos para o tratamento de doenças relacionadas com interleucina-6
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
DE602005020655D1 (de) Carboxamid-spirolactam-cgrp-rezeptor-antagonisten
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
BR9911621A (pt) Bifenil sulfonamidas como antagonista duplos de receptor de angiotensina endotelina
BR0209312A (pt) Composição alimentìcia de isolado de proteìna de canola
MXPA03004549A (es) Derivados de 3-arilindola y su uso como agonistas del receptor cb2.
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
BR0214577A (pt) Copolìmero de etileno/alfa-olefina feito com uma combinação de um catalisador de sìtio-único/sìtio-não-único, sua preparação e uso
AR029942A1 (es) Compuestos derivados de 1,3-dihidro-2h-indol-2-ona, su utilizacion, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden, medicamentos constituidos por dichos compuestos y compuestos intermediarios
EA200401455A1 (ru) Производные бензоксазина в качестве модуляторов 5-htи их применение
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
DE50213012D1 (de) Polyamide-zusammensetzungen enthaltend antioxidantien
DOP2002000325A (es) Antagonistas de receptores de histamina
BR0308890A (pt) Composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2025 DE 27/10/2009.